Skip to content

Inventories at other companies

Guardant Health logo
Guardant HealthGH
$83.85M+8.5%
Natera, Inc. logo
Natera, Inc.NTRA
$70.72M+40.4%
Revvity logo
RevvityRVTY
$387.51M+1.6%
Agilent Technologies logo
Agilent TechnologiesA
$1.09B+9.9%
TEC
Bio-TechneTECH
$201.18M+5.3%
Quest Diagnostics logo
Quest DiagnosticsDGX
$225M+19.0%

Other financials

Income statement

See full
Revenue$348.1M+36.1%
Operating income-$84.7M-23.3%
Net income-$125.9M-85.1%
EPS (diluted)-$0.71-77.5%

Balance sheet

See full
Cash & equivalents$525.9M+243%
Total debt$85.4M+49.8%
Total equity$416.4M+27.7%
Total assets$2.1B+38.4%

Cash flow

See full
Operating cash flow-$73.3M+30.6%
CapEx$8.2M+295%
Free cash flow-$81.5M+24.3%

Valuation

See full
Market cap$9.13B-2.7%
Enterprise value$8.69B-6.9%
P/S6.7×-5.0×

Profitability

See full
Operating margin-19.7%-8.6pp
Net margin-22.2%-9.5pp
FCF margin-54.5%

Returns & leverage

See full
Return on equity-81.6%
Debt / equity0.2×0.0×
Current ratio3.3×+1.6×

Where this comes from

Reported directly by Tempus AI, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InventoryNet.

The official record: Tempus AI, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tempus AI, Inc.'s inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tempus AI, Inc.'s inventories?
Tempus AI, Inc. (TEM) reported inventories of $51.83M in Q1 2026.
How has Tempus AI, Inc.'s inventories changed year-over-year?
Tempus AI, Inc.'s inventories increased by 2.7% year-over-year, from $50.49M to $51.83M.
What is the long-term trend for Tempus AI, Inc.'s inventories?
Over 2 years (2022 to 2025), Tempus AI, Inc.'s inventories has grown at a 1149.3% compound annual growth rate (CAGR), from $1.31M to $204.79M.
What does inventories mean?
The total value of physical goods and materials held by the company for production or sale.
How do you interpret inventories?
Increasing inventory levels may indicate anticipated growth or potential overstocking, while decreasing levels may suggest supply chain efficiency or slowing demand.
How does inventories compare across companies?
Compared against inventory turnover ratios of other diagnostic and life sciences companies.